A recent LA Times article discusses approaches to treating meth addiction.

CBAM faculty have been working on this topic for nearly two decades.

Treatments that would prevent the effects of meth on a user’s brain and body are very promising, but much work still needs to be done to determine the safest and most effective method to achieve this in humans. Targeting the immune response and inflammation that occurs with chronic meth use is also a promising approach to immunotherapy for meth addiction. In this case antibodies or a medication would be used to reduce brain inflammation resulting from meth use, thereby improving brain function and reducing risk of relapse. In the future a combination of antibodies to reduce meth entry into the brain and medication to improve brain function may provide a successful treatment for meth addiction.

To find out more, visit us at www.uclacbam.org/meth or call us at 866-449-UCLA.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.